|
|
|||
| |||||||||||||||||||||||||||||||||||||||
Thomas Henry Huxley1
On August 31, 2005, I resigned my post of assistant commissioner for women's health and director of the Office of Women's Health at the Food and Drug Administration (FDA). The agency leadership had chosen to delay indefinitely a decision about switching emergency contraception to nonprescription status. I believed that in doing so, they were disregarding the scientific and clinical evidence and the established review process and were taking an action that harms women's health by denying them appropriate access to a product that can reduce the rate of
Source Information
Dr. Wood was the assistant commissioner for women's health and director of the Office of Women's Health at the Food and Drug Administration, Rockville, Md., from November 2000 to August 2005. She is an adjunct associate professor at the School of Public Affairs at American University, Washington, D.C.
An interview with Dr. Wood can be heard at www.nejm.org.
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |